sponsored links

Ariad leukemia drug helps 47 percent of patient: study (Reuters)

Sponsored Links

Reuters – Early results from a pivotal trial of Ariad Pharmaceuticals Inc’s experimental leukemia drug ponatinib show it is effective in nearly half of patients who had stopped responding to currently available drugs.

View full post on Yahoo! News: Health News


Sponsored Links
You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

AddThis Social Bookmark Button

Leave a Reply

You must be logged in to post a comment.